Focus on vitamin D and the adrenal gland
2015-01-01 Muscogiuri, G; Altieri, B; Penna-Martinez, M; Badenhoop, K.
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
2019-01-01 Altieri, B; Di Dato, C; Martini, C; Sciammarella, C; Di Sarno, A; Colao, A; Faggiano, A; on behalf of NIKE, Group
Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma
2024-01-01 Lippert, J; Smith, G; Appenzeller, S; Landwehr, Ls; Prete, A; Steinhauer, S; Asia, M; Urlaub, H; Elhassan, Ys; Kircher, S; Arlt, W; Fassnacht, M; Altieri, B; Ronchi, Cl
Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus
2020-01-01 Giannetta, E; Guarnotta, V; Altieri, B; Sciammarella, C; Guadagno, E; Malandrino, P; Puliani, G; Feola, T; Isidori, Am; Colao, A; Faggiano, A
"Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma"
2024-01-01 Landwehr, Ls; Altieri, B; Sbiera, I; Remde, H; Kircher, S; Olabe, J; Sbiera, S; Kroiss, M; Fassnacht, M
Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety
2024-01-01 Malandrino, P; Feola, T; Mikovic, N; Cannavale, G; Molfetta, Sd; Altieri, B; Mancini, C; Ferolla, P; Colao, A; Faggiano, A; Nike, Group
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection
2023-01-01 Altieri, B; La Salvia, A; Modica, R; Marciello, F; Mercier, O; Filosso, Pl; de Latour, Br; Giuffrida, D; Campione, S; Guggino, G; Fadel, E; Papotti, M; Colao, A; Scoazec, Jy; Baudin, E; Faggiano, A.
Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report
2013-01-01 Capozzi, A; Della Casa, S; Altieri, B; Pontecorvi, A
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution
2024-01-01 Tourigny, Ds; Altieri, B; Secener, Ka; Sbiera, S; Schauer, Mp; Arampatzi, P; Herterich, S; Sauer, S; Fassnacht, M; Ronchi, Cl
Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study
2019-01-01 Muscogiuri, G; Barrea, L; Di Somma, C; Altieri, B; Vecchiarini, M; Orio, F; Spinosa, T; Colao, A; Savastano, S
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma
2020-01-01 Puglisi, S; Calabrese, A; Basile, V; Ceccato, F; Scaroni, C; Altieri, B; Della Casa, S; Loli, P; Pivonello, R; De Martino, Mc; Canu, L; Russo, M; Badalamenti, G; Torlontano, M; Stigliano, A; Ferraù, F; Arnaldi, G; Saba, L; Quirino, A; Perotti, P; Berchialla, P; Terzolo, M
Management of Patients with Glucocorticoid-Related Diseases and COVID-19
2021-01-01 Chifu, I; Detomas, M; Dischinger, U; Kimpel, O; Megerle, F; Hahner, S; Fassnacht, M; Altieri, B
Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study
2020-01-01 Altieri, B; Sbiera, S; Herterich, S; De Francia, S; Della Casa, S; Calabrese, A; Pontecorvi, A; Quinkler, M; Kienitz, T; Mannelli, M; Canu, L; Angelousi, A; Chortis, V; Kroiss, M; Terzolo, M; Fassnacht, M; Ronchi, Cl
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas
2018-01-01 Laufs, V; Altieri, B; Sbiera, S; Kircher, S; Steinhauer, S; Beuschlein, F; Quinkler, M; Willenberg, Hs; Rosenwald, A; Fassnacht, M; Ronchi, Cl
The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors
2018-01-01 Altieri, B; Colao, A; Faggiano, A
Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome
2015-01-01 Ronchi, Cl; Sbiera, S; Altieri, B; Steinhauer, S; Wild, V; Bekteshi, M; Kroiss, M; Fassnacht, M; Allolio, B.
Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma
2023-01-01 Kimpel, O; Altieri, B; Dischinger, U; Fuss, Ct; Kurlbaum, M; Fassnacht, M
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma
2017-01-01 Sbiera, S; Sbiera, I; Ruggiero, C; Doghman-Bouguerra, M; Korpershoek, E; de Krijger, Rr; Ettaieb, H; Haak, H; Volante, M; Papotti, M; Reimondo, G; Terzolo, M; Luconi, M; Nesi, G; Mannelli, M; Libé, R; Ragazzon, B; Assié, G; Bertherat, J; Altieri, B; Fadda, G; Rogowski-Lehmann, N; Reincke, M; Beuschlein, F; Fassnacht, M; Lalli, E
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma
2014-01-01 Ronchi, Cl; Sbiera, S; Volante, M; Steinhauer, S; Scott-Wild, V; Altieri, B; Kroiss, M; Bala, M; Papotti, M; Deutschbein, T; Terzolo, M; Fassnacht, M; Allolio, B
Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism
2022-01-01 Detomas, M; Altieri, B; Chifu, I; Remde, H; Zhou, X; Landwehr, Ls; Sbiera, S; Kroiss, M; Fassnacht, M; Deutschbein, T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Focus on vitamin D and the adrenal gland | 1-gen-2015 | Muscogiuri, G; Altieri, B; Penna-Martinez, M; Badenhoop, K. | |
| Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management | 1-gen-2019 | Altieri, B; Di Dato, C; Martini, C; Sciammarella, C; Di Sarno, A; Colao, A; Faggiano, A; on behalf of NIKE, Group | |
| Circulating cell-free DNA-based biomarkers for prognostication and disease monitoring in adrenocortical carcinoma | 1-gen-2024 | Lippert, J; Smith, G; Appenzeller, S; Landwehr, Ls; Prete, A; Steinhauer, S; Asia, M; Urlaub, H; Elhassan, Ys; Kircher, S; Arlt, W; Fassnacht, M; Altieri, B; Ronchi, Cl | |
| Calcitonin in thyroid and extra-thyroid Neuroendocrine Neoplasms: the two-faced Janus | 1-gen-2020 | Giannetta, E; Guarnotta, V; Altieri, B; Sciammarella, C; Guadagno, E; Malandrino, P; Puliani, G; Feola, T; Isidori, Am; Colao, A; Faggiano, A | |
| "Expression and prognostic relevance of PD-1, PD-L1 and CTLA-4 immune checkpoints in adrenocortical carcinoma" | 1-gen-2024 | Landwehr, Ls; Altieri, B; Sbiera, I; Remde, H; Kircher, S; Olabe, J; Sbiera, S; Kroiss, M; Fassnacht, M | |
| Radioligand Therapy in Patients with Lung Neuroendocrine Tumors: A Systematic Review on Efficacy and Safety | 1-gen-2024 | Malandrino, P; Feola, T; Mikovic, N; Cannavale, G; Molfetta, Sd; Altieri, B; Mancini, C; Ferolla, P; Colao, A; Faggiano, A; Nike, Group | |
| Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection | 1-gen-2023 | Altieri, B; La Salvia, A; Modica, R; Marciello, F; Mercier, O; Filosso, Pl; de Latour, Br; Giuffrida, D; Campione, S; Guggino, G; Fadel, E; Papotti, M; Colao, A; Scoazec, Jy; Baudin, E; Faggiano, A. | |
| Chronic low-dose glucocorticoid inhalatory therapy as a cause of bone loss in a young man: case report | 1-gen-2013 | Capozzi, A; Della Casa, S; Altieri, B; Pontecorvi, A | |
| Cellular landscape of adrenocortical carcinoma at single-nuclei resolution | 1-gen-2024 | Tourigny, Ds; Altieri, B; Secener, Ka; Sbiera, S; Schauer, Mp; Arampatzi, P; Herterich, S; Sauer, S; Fassnacht, M; Ronchi, Cl | |
| Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study | 1-gen-2019 | Muscogiuri, G; Barrea, L; Di Somma, C; Altieri, B; Vecchiarini, M; Orio, F; Spinosa, T; Colao, A; Savastano, S | |
| Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma | 1-gen-2020 | Puglisi, S; Calabrese, A; Basile, V; Ceccato, F; Scaroni, C; Altieri, B; Della Casa, S; Loli, P; Pivonello, R; De Martino, Mc; Canu, L; Russo, M; Badalamenti, G; Torlontano, M; Stigliano, A; Ferraù, F; Arnaldi, G; Saba, L; Quirino, A; Perotti, P; Berchialla, P; Terzolo, M | |
| Management of Patients with Glucocorticoid-Related Diseases and COVID-19 | 1-gen-2021 | Chifu, I; Detomas, M; Dischinger, U; Kimpel, O; Megerle, F; Hahner, S; Fassnacht, M; Altieri, B | |
| Effects of germline CYP2W1*6 and CYP2B6*6 Single Nucleotide Polymorphisms on mitotane treatment in adrenocortical carcinoma: a multicenter ENSAT study | 1-gen-2020 | Altieri, B; Sbiera, S; Herterich, S; De Francia, S; Della Casa, S; Calabrese, A; Pontecorvi, A; Quinkler, M; Kienitz, T; Mannelli, M; Canu, L; Angelousi, A; Chortis, V; Kroiss, M; Terzolo, M; Fassnacht, M; Ronchi, Cl | |
| ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas | 1-gen-2018 | Laufs, V; Altieri, B; Sbiera, S; Kircher, S; Steinhauer, S; Beuschlein, F; Quinkler, M; Willenberg, Hs; Rosenwald, A; Fassnacht, M; Ronchi, Cl | |
| The role of Insulin-like Growth Factor (IGF) system in the adrenocortical tumors | 1-gen-2018 | Altieri, B; Colao, A; Faggiano, A | |
| Notch1 pathway in adrenocortical carcinomas: correlation with clinical outcome | 1-gen-2015 | Ronchi, Cl; Sbiera, S; Altieri, B; Steinhauer, S; Wild, V; Bekteshi, M; Kroiss, M; Fassnacht, M; Allolio, B. | |
| Early Detection of Recurrence and Progress Using Serum Steroid Profiling by LC-MS/MS in Patients with Adrenocortical Carcinoma | 1-gen-2023 | Kimpel, O; Altieri, B; Dischinger, U; Fuss, Ct; Kurlbaum, M; Fassnacht, M | |
| Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma | 1-gen-2017 | Sbiera, S; Sbiera, I; Ruggiero, C; Doghman-Bouguerra, M; Korpershoek, E; de Krijger, Rr; Ettaieb, H; Haak, H; Volante, M; Papotti, M; Reimondo, G; Terzolo, M; Luconi, M; Nesi, G; Mannelli, M; Libé, R; Ragazzon, B; Assié, G; Bertherat, J; Altieri, B; Fadda, G; Rogowski-Lehmann, N; Reincke, M; Beuschlein, F; Fassnacht, M; Lalli, E | |
| CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma | 1-gen-2014 | Ronchi, Cl; Sbiera, S; Volante, M; Steinhauer, S; Scott-Wild, V; Altieri, B; Kroiss, M; Bala, M; Papotti, M; Deutschbein, T; Terzolo, M; Fassnacht, M; Allolio, B | |
| Subtype-specific pattern of white blood cell differential in endogenous hypercortisolism | 1-gen-2022 | Detomas, M; Altieri, B; Chifu, I; Remde, H; Zhou, X; Landwehr, Ls; Sbiera, S; Kroiss, M; Fassnacht, M; Deutschbein, T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista72055
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa65
- 2020 - 202617135
- 2010 - 201923036
- 2000 - 200918345
- 1990 - 19998891
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI975
- Elsevier Ltd765
- Elsevier B.V.654
- MDPI AG497
- Elsevier394
- John Wiley and Sons Inc331
- Springer323
- Multidisciplinary Digital Publish...309
- Springer Science and Business Med...301
- Elsevier Inc.267
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS283
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...198
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS181
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2918
- Female1598
- Male1494
- Middle Aged905
- Adult898
- Aged761
- Animals652
- Italy594
- Medicine (all)464
- COVID-19460
Lingua
- eng43627
- ita9147
- fre232
- spa124
- ger102
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58737
- reserved8054
- open3774
- partially open822
- restricted667
- embargoed2
- mixed1